Steve Valiquette
Stock Analyst at Barclays
(1.53)
# 3,515
Out of 5,242 analysts
147
Total ratings
47.42%
Success rate
-1.95%
Average return
Main Sectors:
Stocks Rated by Steve Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BKD Brookdale Senior Living | Maintains: Equal-Weight | $8 → $9.5 | $13.38 | -29.00% | 6 | Nov 10, 2025 | |
| TDOC Teladoc Health | Maintains: Overweight | $10 → $12 | $6.57 | +82.65% | 13 | Oct 31, 2024 | |
| MCK McKesson | Maintains: Overweight | $596 → $616 | $766.50 | -19.63% | 6 | Aug 8, 2024 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $8 → $9 | $2.56 | +251.56% | 7 | Mar 1, 2024 | |
| HR Healthcare Realty Trust | Maintains: Equal-Weight | $25 → $24 | $20.36 | +17.88% | 4 | Aug 11, 2023 | |
| CVS CVS Health | Maintains: Overweight | $89 → $86 | $93.32 | -7.84% | 14 | Aug 3, 2023 | |
| CNC Centene | Maintains: Overweight | $86 → $85 | $57.77 | +47.14% | 6 | Jul 31, 2023 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $275 → $300 | $392.56 | -23.58% | 4 | Jun 28, 2023 | |
| LTC LTC Properties | Maintains: Underweight | $35 → $34 | $38.64 | -12.01% | 3 | May 3, 2023 | |
| THC Tenet Healthcare | Maintains: Overweight | $70 → $105 | $178.00 | -41.01% | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $55 | $88.00 | -37.50% | 3 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $13 | $20.71 | -37.23% | 11 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $132 → $142 | $162.45 | -12.59% | 2 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $5 | $37.99 | -86.84% | 4 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $57 | $104.45 | -45.43% | 2 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $78 → $82 | $216.01 | -62.04% | 5 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $19.64 | -8.35% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $31 | $48.26 | -35.76% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $375 | $181.26 | +106.89% | 3 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $20 → $19 | $41.01 | -53.67% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $570 | $303.68 | +87.70% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $70 → $64 | $200.61 | -68.10% | 4 | May 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $275 → $310 | $282.02 | +9.92% | 16 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $495 → $565 | $382.48 | +47.72% | 3 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $150 → $75 | $0.6771 | +10,976.65% | 4 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $26 → $19 | $7.37 | +157.80% | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $6 → $10 | $2.77 | +261.01% | 10 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $20 | $7.67 | +160.76% | 1 | May 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $260 | $76.35 | +240.54% | 1 | Feb 19, 2021 |
Brookdale Senior Living
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $8 → $9.5
Current: $13.38
Upside: -29.00%
Teladoc Health
Oct 31, 2024
Maintains: Overweight
Price Target: $10 → $12
Current: $6.57
Upside: +82.65%
McKesson
Aug 8, 2024
Maintains: Overweight
Price Target: $596 → $616
Current: $766.50
Upside: -19.63%
GoodRx Holdings
Mar 1, 2024
Maintains: Overweight
Price Target: $8 → $9
Current: $2.56
Upside: +251.56%
Healthcare Realty Trust
Aug 11, 2023
Maintains: Equal-Weight
Price Target: $25 → $24
Current: $20.36
Upside: +17.88%
CVS Health
Aug 3, 2023
Maintains: Overweight
Price Target: $89 → $86
Current: $93.32
Upside: -7.84%
Centene
Jul 31, 2023
Maintains: Overweight
Price Target: $86 → $85
Current: $57.77
Upside: +47.14%
HCA Healthcare
Jun 28, 2023
Maintains: Equal-Weight
Price Target: $275 → $300
Current: $392.56
Upside: -23.58%
LTC Properties
May 3, 2023
Maintains: Underweight
Price Target: $35 → $34
Current: $38.64
Upside: -12.01%
Tenet Healthcare
Apr 26, 2023
Maintains: Overweight
Price Target: $70 → $105
Current: $178.00
Upside: -41.01%
Apr 25, 2023
Maintains: Overweight
Price Target: $57 → $55
Current: $88.00
Upside: -37.50%
Apr 25, 2023
Maintains: Equal-Weight
Price Target: $15 → $13
Current: $20.71
Upside: -37.23%
Apr 25, 2023
Upgrades: Equal-Weight
Price Target: $132 → $142
Current: $162.45
Upside: -12.59%
Apr 5, 2023
Maintains: Underweight
Price Target: $13 → $5
Current: $37.99
Upside: -86.84%
Mar 14, 2023
Initiates: Equal-Weight
Price Target: $57
Current: $104.45
Upside: -45.43%
Jan 17, 2023
Maintains: Overweight
Price Target: $78 → $82
Current: $216.01
Upside: -62.04%
Jan 17, 2023
Maintains: Overweight
Price Target: $20 → $18
Current: $19.64
Upside: -8.35%
Jan 17, 2023
Maintains: Equal-Weight
Price Target: $33 → $31
Current: $48.26
Upside: -35.76%
Jan 4, 2023
Maintains: Overweight
Price Target: $400 → $375
Current: $181.26
Upside: +106.89%
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $41.01
Upside: -53.67%
Jul 28, 2022
Maintains: Overweight
Price Target: $500 → $570
Current: $303.68
Upside: +87.70%
May 26, 2022
Downgrades: Equal-Weight
Price Target: $70 → $64
Current: $200.61
Upside: -68.10%
May 23, 2022
Maintains: Overweight
Price Target: $275 → $310
Current: $282.02
Upside: +9.92%
Mar 30, 2022
Maintains: Overweight
Price Target: $495 → $565
Current: $382.48
Upside: +47.72%
Nov 10, 2021
Downgrades: Equal-Weight
Price Target: $150 → $75
Current: $0.6771
Upside: +10,976.65%
Aug 12, 2021
Upgrades: Overweight
Price Target: $26 → $19
Current: $7.37
Upside: +157.80%
Aug 3, 2021
Maintains: Underweight
Price Target: $6 → $10
Current: $2.77
Upside: +261.01%
May 24, 2021
Initiates: Overweight
Price Target: $20
Current: $7.67
Upside: +160.76%
Feb 19, 2021
Reinstates: Overweight
Price Target: $260
Current: $76.35
Upside: +240.54%